Back to DANSKE BANK A/S DANSKE BANK A/S

XERSXERS

2 quarters

Position history for DANSKE BANK A/SDANSKE BANK A/S's holdings in XERIS BIOPHARMA HOLDINGS INC

No. Danske Bank exited its XERS (Xeris Biopharma Holdings) position in Q4 2024. Its Q3 2024 13F listed 2 shares worth $6. Danske Bank first reported XERS in Q3 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$6

Total Shares Change

-2

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$3.38
0
2024-Q3
New
2
—
$60.0%$2.87
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used